genOway Shanghai at the Chinese Biopharmaceutical Association meeting 2024
Conference
The genOway Shanghai team participated in the CBA annual meeting, which hosted over 10,000 attendees, introducing genOway’s preclinical models to the Chinese scientific community.
During the conference, Marième NDJIM, PhD, Senior Business Developer at genOway, delivered an insightful presentation on how the predictability of our models accelerates the development of safer and more effective next-generation drugs.
We are very happy about the collaboration between our teams in France and China and the enthusiasm of all the clients we met.
Other news & events
Scientific excellence
From model design to experimental results
Tailor-made solutions adapted to scientific questions
Robust validation data on catalog models
Comprehensive dataset package
Generated with biopharma partners and in-house
Customer care
Scientific follow-up and advice along the project
Collaborative approach for problem solving and development of innovative models
Easy and fast access to models
Breeding facilities in US and Europe
Certified health status from professional breeders